EcoDrugPlus

Ensembl ID : HMEL017170
Gene Symbol: -
External references: -
485 Possible Orthologues:

Ensembl ID : HMEL017248
Gene Symbol: -
External references: -
722 Possible Orthologues:

Ensembl ID : HMEL017265
Gene Symbol: -
External references: -
603 Possible Orthologues:

Ensembl ID : HMEL017319
Gene Symbol: -
External references: -
89 Possible Orthologues:

Ensembl ID : HMEL017328
Gene Symbol: -
External references: -
292 Possible Orthologues:

Ensembl ID : HMEL017329
Gene Symbol: -
External references: -
292 Possible Orthologues:

Ensembl ID : HMEL017406
Gene Symbol: -
External references: -
539 Possible Orthologues:

Ensembl ID : HMEL017407
Gene Symbol: -
External references: -
547 Possible Orthologues:

Ensembl ID : HMEL017410
Gene Symbol: -
External references: -
536 Possible Orthologues:

Ensembl ID : HMEL017415
Gene Symbol: -
External references: -
240 Possible Orthologues:

Ensembl ID : HMEL017549
Gene Symbol: -
External references: -
43 Possible Orthologues:

Ensembl ID : HMEL017552
Gene Symbol: -
External references: -
77 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).